Internal Medicine, Pulmonary Disease · Richmond, VA
NPI
1497074561
Since 2010
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
6600 W Broad St Ste 300
Richmond, VA, 23230
Phone (804) 320-4243
Groups this clinician bills Medicare through
Medicare paid, 2024
$916K
30,238 services
Medicare patients, 2024
1,004
Average age 75
Drug cost, 2024
$1.4M
4,676 prescriptions
Company payments, 2025
$6,133
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John T Sentz was code J2182 (injection, mepolizumab, 1 mg), 10,300 times for 36 patients. In total John T Sentz billed 30,238 services in 54 codes, and Medicare paid $916K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2182 Injection, mepolizumab, 1 mg | Office | 10,300 | 36 | $23.86 | $246K |
| J2357 Injection, omalizumab, 5 mg | Office | 9,600 | 51 | $29.86 | $287K |
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 5,460 | 13 | $14.27 | $78K |
| 99214 Office E&M - Established | Office | 1,188 | 585 | $92.76 | $110K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 445 | 69 | $44.79 | $20K |
| 96372 Injection Administration | Office | 440 | 110 | $11.10 | $4,886 |
| 99454 E&M - Miscellaneous | Office | 356 | 57 | $35.72 | $13K |
| 99457 E&M - Miscellaneous | Office | 290 | 58 | $36.99 | $11K |
| 99213 Office E&M - Established | Office | 176 | 145 | $62.59 | $11K |
| 94726 Pulmonary Function Testing | Office | 152 | 150 | $41.05 | $6,240 |
| 94729 Pulmonary Function Testing | Office | 150 | 148 | $41.65 | $6,247 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 150 | 135 | $12.74 | $1,910 |
| 94060 Pulmonary Function Testing | Office | 103 | 103 | $27.90 | $2,874 |
| 99204 Office E&M - New | Office | 99 | 99 | $120.44 | $12K |
| 99406 Behavioral Health Services | Office | 95 | 56 | $14.19 | $1,348 |
By year: 2022 $590K for 17,487 services; 2023 $886K for 27,448 services; 2024 $916K for 30,238 services.
Medicare prescription drug claims, 2024
In 2024, the drug John T Sentz prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 729 prescriptions and refills. In total John T Sentz wrote 4,676 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 729 | 904 | 149 | $566K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 584 | 694 | 219 | $15K |
| Montelukast Sodium Generic | 510 | 1,184 | 148 | $4,556 |
| Prednisone Generic | 488 | 719 | 259 | $2,448 |
| Azithromycin Generic | 469 | 578 | 149 | $7,336 |
| Breo Ellipta Fluticasone/Vilanterol | 210 | 309 | 42 | $119K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 127 | 177 | 38 | $107K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 108 | 142 | 25 | $17K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 93 | 103 | 23 | $12K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 91 | 121 | 23 | $56K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 85 | 85 | 63 | $538 |
| Ventolin Hfa Albuterol Sulfate | 72 | 77 | 21 | $4,292 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 69 | 83 | 17 | $35K |
| Symbicort Budesonide/Formoterol Fumarate | 68 | 88 | 19 | $20K |
| Levofloxacin Generic | 65 | 65 | 52 | $254 |
Brand drugs: 2,272 claims; generic drugs: 2,404 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John T Sentz $6,133 ($6,133 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $4,705.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 29 | $4,705 |
| GlaxoSmithKline, LLC. GSK | 33 | $423 |
| Amgen Inc. AMGN | 13 | $260 |
| Genzyme Corporation SNY | 7 | $138 |
| Pfizer Inc. PFE | 5 | $103 |
| Insmed, Inc. INSM | 4 | $81.09 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $78.94 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $66.46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51.05 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $47.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.